Dailey Tyler A, Berven Michael D, Vroman Penny J
Department of Radiology, San Antonio Military Medical Center, Fort Sam Houston, Texas
Department of Radiology, San Antonio Military Medical Center, Fort Sam Houston, Texas.
J Nucl Med Technol. 2014 Dec;42(4):299-301. doi: 10.2967/jnmt.114.138073. Epub 2014 Aug 28.
The goal of this teaching case study is to demonstrate the novel use of (99m)Tc-HMPAO-labeled white blood cells (WBCs) in diagnosing chronic recurrent multifocal osteomyelitis (CRMO). (99m)Tc-HMPAO-labeled white blood cells were utilized to diagnose CRMO. Classically, CRMO is evaluated scintigraphically using (99m)Tc-methylene diphosphonate/hydroxymethylene diphosphonate. (99m)Tc-HMPAO-labeled WBCs were chosen over (111)In-labeled WBCs because of the former's improved imaging characteristics and decreased radiation dose. (99m)Tc-HMPAO-labeled WBCs were successful in diagnosing CRMO. (99m)Tc-HMPAO-labeled WBC scanning is specific for the diagnosis of CRMO.
本教学案例研究的目的是展示(99m)锝-六甲基丙烯胺肟标记的白细胞(WBC)在诊断慢性复发性多灶性骨髓炎(CRMO)中的新用途。(99m)锝-六甲基丙烯胺肟标记的白细胞被用于诊断CRMO。传统上,CRMO通过(99m)锝-亚甲基二膦酸盐/羟亚甲基二膦酸盐进行闪烁显像评估。选择(99m)锝-六甲基丙烯胺肟标记的白细胞而非(111)铟标记的白细胞,是因为前者具有更好的成像特性且辐射剂量更低。(99m)锝-六甲基丙烯胺肟标记的白细胞成功诊断了CRMO。(99m)锝-六甲基丙烯胺肟标记的白细胞扫描对CRMO的诊断具有特异性。